Ascentage (AAPG): Balans kapitallashuviga qarzlar

Ascentage Pharma Group International (AAPG) grafik logotipi

Ascentage Pharma Group onkologiya sohasida istiqbolli yetakchi maqomini qo'lga kiritib, global olimlar va investorlarning ishonchini qozondi. Biroq, Pekin va Vashington o'rtasidagi savdo urushlari biodatalarni uzatish va instrumentlarni sertifikatlashtirish bo'yicha murakkabliklarni keltirib chiqarmoqda. GURU.Markets platformasida pul formatida vizuallashtirilgan va ko'rsatkich 3.46 ni tashkil etgan bozor tendentsiyasi, Yan Dapinning saratonning ilg'or terapiyalariga investitsiyalarni jalb qilish strategiyasini to'ldiradi.

Ascentage Pharma Group (AAPG) - Balans qiymatiga qarzlar 25.01.2025dan 28.10.2026gacha

Ascentage Pharma Group International (AAPG) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Ascentage Pharma Group|AAPG - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Ascentage Pharma Corp|AAPG - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Ascentage Pharma|AAPG - Kompaniyaning xususiy kapitali|Bozor qiymatining balans qiymatiga nisbati ascentage.com|AAPG - Aktivlarning umumiy qiymati
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Ascentage Pharma Group|AAPG - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Ascentage|AAPG - Kompaniyaning umumiy qarzi|Qarzning balans qiymatiga nisbati Ascentage Pharma Corp
Kompaniyaning barcha koʻrsatkichlari tahlili:Ascentage Pharma Group AAPG
Ascentage Pharma Group International asosiy tovari

Ushbu ko'rsatkich umumiy qarzdorlikni kapitalning balans qiymati bilan taqqoslab, moliyaviy leveraj darajasi va bankrotlik xavfini aniqlaydi. Chidamlilikka ega saraton bilan kurashish uchun murakkab molekulalar ishlab chiquvchi Ascentage Pharma Group (AAPG) uchun qarzdorlikning kapitalizatsiyaga nisbati bio-kimyoviy innovatsiyalarning agressiv moliyalashtirilishi va aktivlar tuzilmasining barqarorligi o'rtasidagi muvozanatni aks ettiradi.

Ascentage Pharma Group kimlar bilan raqobatlashadi

ONC - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati halozyme.com HALO|RVMD: Balans kapitallashuviga qarzlar|CGON - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar URGN|BCAX (Bicara Corp) - Balans qiymatiga qarzlar|PSNL - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati erasca.com (ERAS)|Delcath Systems (DCTH) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Y-mAbs Therapeutics Inc (YMAB)|Aura Bio - Balans kapitallashuviga qarzlar|CADL - Qarzning balans qiymatiga nisbati|Accuray Incorporated - Qarzning balans qiymatiga nisbati|SLS: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Actuate Therapeutics ACTU|Citius Oncology Inc. (CTOR) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar HURA (TuHURA Biosciences Inc.)|Balans qiymatiga qarzlar Protara Tx|Balans kapitallashuviga qarzlar FATE|Balans kapitallashuviga qarzlar WHWK (aadibio.com)|Qarzning balans kapitallashuviga nisbati TCRX|Sof aktivlarga qarzlar Champions Oncology Inc CSBR|XBIT: Balans kapitallashuviga qarzlar|CVM - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar OSTX|RADX (radiopharmtheranostics.com) - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Artiva Biotherapeutics Inc. (ARTV)|Qarzning balans qiymatiga nisbati Adlai Nortye Limited (ANL)|Qarzning balans qiymatiga nisbati Veru Pharma|Qarzning balans kapitaliga nisbati Tempest Therapeutics Corp (TPST)|Balans kapitallashuviga qarzlar XLO (Xilio Therapeutics)|Balans kapitallashuviga qarzlar Renovaro Biosciences RENB|Balans kapitallashuviga qarzlar MURA|KAPA - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar OKUR|Balans qiymatiga qarzlar CytoMed Therapeutics Limited|CRIS - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati APLM|THAR - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati advanbiomed.com (ADVB)|Balans kapitallashuviga qarzlar Genprex, Inc|Qarzning sof aktivlarga nisbati Calidi Biotherapeutics Inc. CLDI|Sunshine Biopharma, Inc. - Balans kapitallashuviga qarzlar|XBIO: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Salarius Pharmaceuticals, Inc. SLRX|PPBT (Purple Biotech Ltd) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati AONC|Qarzning balans qiymatiga nisbati BeiGene Ltd|Balans kapitallashuviga qarzlar CKPT|Balans kapitallashuviga qarzlar elevationoncology.com ELEV|Qarzning balans qiymatiga nisbati iCAD|Qarzning sof aktivlarga nisbati Ikena Oncology Inc. IKNA|Balans kapitallashuviga qarzlar NTBL|VIRX: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati MorphoSys AG MOR|NAYA (nayabiosciences.com) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati AAPGV (Ascentage Pharma)